The full content of Annals is available to subscribers

Subscribe/Learn More  >
Therapeutics |

Review: Antidepressants increase remission and clinical improvement in bulimia nervosa

John F. Morgan, MD, MA
[+] Article, Author, and Disclosure Information

Source of funding: Not stated.

For correspondence: Dr. J. Bacaltchuk, Universidade Federal de São Paulo, São Paulo—SP, Brazil. E-mail bacaltc@ibm.net.

Ann Intern Med. 2002;136(3):106. doi:10.7326/ACPJC-2002-136-3-106
Text Size: A A A

Question: In patients with bulimia nervosa (BN), are antidepressants effective for increasing remission and clinical improvement?

Data sources: Studies were identified by searching MEDLINE; EMBASE/Excerpta Medica; LILACS; PsycLIT; SCISEARCH; the Cochrane Depression, Anxiety, and Neurosis Group Database of Trials; the Cochrane Controlled Trials Register; Clinical Evidence; and reference lists. The International Journal of Eating Disorders was also hand searched, and authors and pharmaceutical companies were contacted.

Study selection: Studies were selected if they were randomized controlled trials (RCTs) that compared any antidepressant with placebo for ≥ 4 weeks in patients with BN. RCTs were excluded if patients had binge-eating or purging-type anorexia nervosa or binge-eating disorder.

Data extraction: 2 reviewers assessed the quality of RCTs and extracted data on patients, study characteristics, drug regimens, and outcomes (including remission [100% reduction in binge or purge episodes], clinical improvement ≥ 50% reduction in binge or purge episodes], and dropouts).

Main results: 16 RCTs (1300 patients) met the selection criteria. Any antidepressant was better than placebo for increasing remission at a mean follow-up of 8 weeks (8 RCTs) and clinical improvement at a mean follow-up of 9 weeks (8 RCTs) (Table). Groups did not differ for dropout rates (14 RCTs) (Table).

Conclusion: In patients with bulimia nervosa, antidepressants are effective in the short term for increasing remission and clinical improvement rates.

Antidepressants vs placebo for bulimia nervosa at 6 to 16 weeks*

OutcomesAntidepressant typeWeighted event ratesRBI (95% CI)NNT (CI)
RemissionAll types20% vs 7.9%105% (32 to 219)9 (6 to 16)
TCAs14% vs 9.1%136% (−4 to 476)Not significant
MAOIs25% vs 6.3%229% (−22 to 1289)Not significant
Other antidepressants15% vs 0%664% (−1 to 5773)7 (4 to 27)
Clinical improvementAll types64% vs 33%84% (38 to 145)4 (3 to 5)
TCAs77% vs 17%294% (59 to 872)2 (2 to 3)
SSRIs58% vs 38%51% (26 to 81)5 (4 to 9)
Other antidepressants44% vs 8.2%321% (74 to 919)3 (3 to 5)
DropoutsSSRIs34% vs 40%18% (1 to 32)Not significant
Other antidepressants30% vs 32%6% (−83 to 52)Not significant
All types34% vs 31%3% (−20 to 32)Not significant
TCAs26% vs 11%93% (15 to 225)Not significant
MAOIs34% vs 29%20% (−33 to 113)Not significant

*MAOIs = monoamine oxidase inhibitors; SSRIs = selective serotonin reuptake inhibitors; TCAs = tricyclic antidepressants. Other abbreviations defined in Glossary; RBI, RRR, RRI, NNT, NNH, and CI calculated from data in article.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.